Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice
- PMID: 16778196
- DOI: 10.1158/0008-5472.CAN-05-4592
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice
Abstract
The effect of prolonged antibiotic treatments on tumor development was evaluated in proto-neu transgenic mice, which spontaneously develop mammary carcinomas. Virgin transgenic mice were treated with metronidazole/ciprofloxacin or gentamicin through the drinking water. The hazard ratio [HR; 95% confidence interval (95% CI)] of breast cancer occurrence in metronidazole/ciprofloxacin-treated mice was more than triple that for controls [3.11 (1.13-8.53); P = 0.028], whereas only a slight increase in HR (95% CI) was observed in gentamicin-treated mice [1.39 (0.56-3.47); P = 0.481]. Tumor growth rate in gentamicin-treated mice was significantly faster than in untreated control mice (P = 0.043). Moreover, mammary glands from mice treated with either antibiotic regimen showed increased lobulization, with more numerous and more developed terminal ductal lobular units than in controls. These results indicate that prolonged exposure to relevant doses of antibiotics affects the mammary glands in this particular model of HER-2/neu transgenic mice; further studies to understand the precise mechanism by which antibiotic treatments influence mammary gland differentiation are critical.
Similar articles
-
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.Cancer Res. 2003 May 15;63(10):2425-33. Cancer Res. 2003. PMID: 12750262
-
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.Cancer Res. 2005 Feb 1;65(3):1071-8. Cancer Res. 2005. PMID: 15705909
-
Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.Cancer Res. 2000 Jan 15;60(2):273-5. Cancer Res. 2000. PMID: 10667575
-
Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.Int J Oncol. 2009 Feb;34(2):517-28. Int J Oncol. 2009. PMID: 19148488
-
Ethanol and experimental breast cancer: a review.Alcohol Clin Exp Res. 1997 Apr;21(2):334-9. Alcohol Clin Exp Res. 1997. PMID: 9113272 Review.
Cited by
-
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies.Imeta. 2024 Jan 1;3(1):e156. doi: 10.1002/imt2.156. eCollection 2024 Feb. Imeta. 2024. PMID: 38868510 Free PMC article. Review.
-
The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.Acta Pharm Sin B. 2024 Apr;14(4):1560-1591. doi: 10.1016/j.apsb.2023.11.018. Epub 2023 Nov 15. Acta Pharm Sin B. 2024. PMID: 38572104 Free PMC article. Review.
-
Antimicrobial Transformation Products in the Aquatic Environment: Global Occurrence, Ecotoxicological Risks, and Potential of Antibiotic Resistance.Environ Sci Technol. 2023 Jul 4;57(26):9474-9494. doi: 10.1021/acs.est.2c09854. Epub 2023 Jun 19. Environ Sci Technol. 2023. PMID: 37335844 Free PMC article. Review.
-
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine.Front Oncol. 2022 Jul 13;12:947188. doi: 10.3389/fonc.2022.947188. eCollection 2022. Front Oncol. 2022. PMID: 35912227 Free PMC article. Review.
-
Roles of Microbiota in Cancer: From Tumor Development to Treatment.J Oncol. 2022 Mar 23;2022:3845104. doi: 10.1155/2022/3845104. eCollection 2022. J Oncol. 2022. PMID: 35342407 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
